Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Sampath

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|August 16, 2002
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporineDeepa Sampath, Zheng Shi, William Plunkett
Molecular Cancer Therapeutics|April 5, 2007
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogationBrett Ewald, Deepa Sampath, William Plunkett
Oncogene|December 10, 2003
Mechanisms of apoptosis induction by nucleoside analogsDeepa Sampath, V Ashutosh Rao, William Plunkett
Blood|September 7, 2006
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removalMazin A Moufarij, Deepa Sampath, Michael J Keating, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 4, 2019
Explaining Gene Expression Using Twenty-One MicroRNAsAmir Asiaee, Zachary B Abrams, Samantha Nakayiza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonucleaseAlma Zecevic, Deepa Sampath, Brett Ewald, et al.
Future Oncology (London, England)|October 12, 2007
miRNAs and their potential for use against cancer and other diseasesEsmerina Tili, Jean-Jacques Michaille, Varsha Gandhi, et al.
Blood|November 19, 2005
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trialDeepa Sampath, Jorge Cortes, Zeev Estrov, et al.
Blood|November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaDeepa Sampath, Chaomei Liu, Karthik Vasan, et al.
Journal of Hematology & Oncology|June 30, 2021
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylationShaneice Mitchell, Pu Zhang, Matthew Cannon, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|August 16, 2002
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporineDeepa Sampath, Zheng Shi, William Plunkett
Molecular Cancer Therapeutics|April 5, 2007
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogationBrett Ewald, Deepa Sampath, William Plunkett
Oncogene|December 10, 2003
Mechanisms of apoptosis induction by nucleoside analogsDeepa Sampath, V Ashutosh Rao, William Plunkett
Blood|September 7, 2006
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removalMazin A Moufarij, Deepa Sampath, Michael J Keating, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 4, 2019
Explaining Gene Expression Using Twenty-One MicroRNAsAmir Asiaee, Zachary B Abrams, Samantha Nakayiza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonucleaseAlma Zecevic, Deepa Sampath, Brett Ewald, et al.
Future Oncology (London, England)|October 12, 2007
miRNAs and their potential for use against cancer and other diseasesEsmerina Tili, Jean-Jacques Michaille, Varsha Gandhi, et al.
Blood|November 19, 2005
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trialDeepa Sampath, Jorge Cortes, Zeev Estrov, et al.
Blood|November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaDeepa Sampath, Chaomei Liu, Karthik Vasan, et al.
Journal of Hematology & Oncology|June 30, 2021
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylationShaneice Mitchell, Pu Zhang, Matthew Cannon, et al.
Pageof 6